Journal article · 2009

Why empirical therapy?

Jean A. Klastersky

Journal of Antimicrobial Chemotherapy, 63(Supplement 1), i14–i15 · Published 16 April 2009 · DOI 10.1093/jac/dkp075

View at the publisherCite this paper

In brief

“Why empirical therapy?” is a 2009 journal article by Jean A. Klastersky, published in Journal of Antimicrobial Chemotherapy. OpenAlex counts 28 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
28
Most cited in
2014 (4)
Field-weighted impact
1.46
References
17
Authors
1

Abstract

Why empirical therapy? Because it works! Empirical antimicrobial therapy is a reasonable, pragmatic approach to limit the ominous threat of Gram-negative sepsis in febrile neutropenic cancer patients. Empirical treatment of occult fungal infection in patients with neutropenia and persistent fever, in spite of initial broad-spectrum antimicrobial coverage, is effective but the role of pre-emptive treatment… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Klastersky, J. A. (2009). Why empirical therapy? Journal of Antimicrobial Chemotherapy, 63(Supplement 1), i14–i15. https://doi.org/10.1093/jac/dkp075

MLA 9

Klastersky, Jean A. “Why empirical therapy?” Journal of Antimicrobial Chemotherapy, vol. 63, no. Supplement 1, 2009, pp. i14–i15. https://doi.org/10.1093/jac/dkp075.

Chicago

Klastersky, Jean A. 2009. “Why empirical therapy?” Journal of Antimicrobial Chemotherapy 63 (Supplement 1): i14–i15. https://doi.org/10.1093/jac/dkp075.

Harvard

Klastersky, J. A. (2009) ‘Why empirical therapy?’, Journal of Antimicrobial Chemotherapy, 63(Supplement 1), pp. i14–i15. doi:10.1093/jac/dkp075.

IEEE

J. A. Klastersky, “Why empirical therapy?,” Journal of Antimicrobial Chemotherapy, vol. 63, no. Supplement 1, pp. i14–i15, 2009, doi: 10.1093/jac/dkp075.

BibTeX

@article{klastersky2009empirical,
  title     = {{Why empirical therapy?}},
  author    = {Klastersky, Jean A.},
  journal   = {Journal of Antimicrobial Chemotherapy},
  year      = {2009},
  volume    = {63},
  number    = {Supplement 1},
  pages     = {i14--i15},
  doi       = {10.1093/jac/dkp075},
  url       = {https://doi.org/10.1093/jac/dkp075}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201322
201444
201511
201622
201733
201822
202022
202211
202411
202511

Its field-weighted citation impact is 1.46: it has been cited 1.46 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • empirical antimicrobial therapy
  • gram-negative sepsis
  • febrile neutropenia
  • cancer patients
  • persistent fever

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Klastersky, J. A. (2009). Why empirical therapy? Journal of Antimicrobial Chemotherapy, 63(Supplement 1), i14–i15. https://doi.org/10.1093/jac/dkp075

How many times has this paper been cited?

28 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Jean A. Klastersky.

What is the DOI of this paper?

10.1093/jac/dkp075, permanently at https://doi.org/10.1093/jac/dkp075. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.